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Abstract
Background: Liver transplantation in presence of diffuse portal vein thrombosis is possible by
using caval blood as portal inflow, through cavo-portal transposition. However, clinical results are
heterogeneous and experimental studies are needed, but similar hemodynamic conditions are
difficult to obtain, especially in small animals. Herein we describe a new simple model of cavo-portal
transposition in rat.
Methods: Spontaneous porto-systemic shunts are induced by subcutaneous transposition of the
spleen. The presence of porto-caval shunts through the spleen permits the interruption of the main
portal vein without splanchnic hemodynamic consequences. Cavo-portal transposition is achieved
by anastomosing the inferior vena cava and the main portal vein after division of the pancreatic-
duodenal vein.
Results: Selective angiography revealed total splanchnic blood diversion to the systemic venous
circulation through the neoformed collaterals; macroscopical examination showed the absence of
any signs of acute portal hypertension with normal liver and gut appearance.
Conclusion: This model of cavoportal transposition is simple, effective and it simulates the clinical
hemodynamic condition since the porto-systemic shunts induced by splenic subcutaneous
transposition correspond to the physiological inframesocolic collaterals during chronic portal
thrombosis in man.
Background
Thrombosis of the portal vein has been a formidable chal-
lenge in liver transplantation and it was historically con-
sidered an absolute contraindication [1]. Refinements in
surgical techniques in the last decades allow surgeons to
overcome portal thrombosis with progressive extensions,
by using phlebothrombectomy, venous jump grafts or
portal vein arterialization [2,3]. Moreover, the use of caval
blood as unique portal inflow has been used recently to
performed liver transplantation in patients with diffuse
splanchnic thrombosis: in this setting graft portal flow has
Published: 16 August 2007
BMC Surgery 2007, 7:18 doi:10.1186/1471-2482-7-18
Received: 1 June 2007
Accepted: 16 August 2007
This article is available from: http://www.biomedcentral.com/1471-2482/7/18
© 2007 Di Domenico et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 6
(page number not for citation purposes)
BMC Surgery 2007, 7:18 http://www.biomedcentral.com/1471-2482/7/18been obtained by end-to-end or end-to-side porto-caval
anastomosis or by reno-portal anastomosis [4-6].
Patients with chronic thrombosis without portal hyper-
tension are the best candidates due to the presence of wide
spontaneous porto-systemic shunts that completely sup-
ply the splancnic vein drainage [7].
The results of these techniques are still heterogeneous and
further experimental and clinical studies are needed to
clarify the role of spontaneous porto-systemic shunt on
liver function after cavoportal transposition [8].
However, similar hemodynamic conditions are difficult
to obtain, especially in small animals [9]; herein we
described a new simple model of cavoportal transposition
in rat with previously induced porto-systemic shunts.
Methods
Eight male Sprague Dawley rats weighting 250–350 gr
were used. Animals were housed for at least 6 days in a
light and temperature controlled room (Laboratory of
General Pathology, University of Genoa, Italy). Rats were
provided access to rodent chow and water ad libitum.
All surgical procedures, including radiological investiga-
tion, were performed under general anesthesia after 12
hour fasting with free access to water.
All animals received humane care: Guiding Principles in
the Care and Use of Laboratory Animals were strictly
adhered to all times together with the recommendations
from the Declaration of Helsinki.
Rats underwent subcutaneous transposition of the spleen.
After four weeks, angiography and macroscopical exami-
nation were performed in four rats (G1) and cavo-portal
transposition in the other four (G2). Selective superior
mesenteric vein angiography and macroscopical examina-
tion were performed in G2 group, 24 hours after cavopor-
tal transposition.
Anesthesia
General anesthesia was induced by intraperitoneal injec-
tion of Zoletil® (Tiletamina + Zolazepam) 80 mg/Kg.
Splenic transposition
Porto-systemic shunts were induced by subcutaneous
spleen transposition [10]. After 1 cm left subcostal inci-
sion, the spleen was mobilized and the abdominal wall
was sutured behind the spleen with 4/0 silk interrupted
stitches between splenic vessel pedicles, that were left
intact. After creation of a subcutaneous pouch, the spleen
was decapsulated by scoring the surface with needle, and
the skin was then sutured in continuos manner.
Cavo-portal transposition
Four weeks after splenic transposition, cavo-portal anasto-
mosis was performed in G2.
After middle-line incision, the inferior vena cava and por-
tal vein were exposed by gently retraction of gut on the left
side; the bowel loops were exteriorized and covered with
saline-soaked gauze in order to prevent dehydration.
Portal vein was completely dissected and the pancreatic-
duodenal vein was cut between 6/0 silk ligatures; the
spleno-mesenteric confluence was then identify. Infrahe-
patic vena cava was completely dissected above the left
renal vein. In order to facilitate the porto-caval anastomo-
sis, the right kidney was fully mobilized.
Portal vein was clamped and cut after 6/0 silk ligature
above the spleno-mesenteric confluence. Right kidney
vessels and the inferior vena cava were clamped; the infra-
hepatic vena cava was cut after 6/0 silk ligature.
End-to-end cavo-portal anastomosis was then performed
using 10/0 Prolene in continuos manner and the liver was
then reperfused.
Radiological investigation
After general anesthesia induction, porto-systemic shunt
formation was evaluated four weeks after splenic transpo-
sition by direct spleen angiography and macroscopical
examination in G1.
Patency of porto-systemic shunts were evaluated by selec-
tive angiography of the superior mesenteric vein 24 hours
after cavo-portal transposition in G2.
Results
Splenic transposition
The surgical procedure required a median of 10 min; the
subcutaneous hematoma resulted by splenic decapsula-
tion, gradually resolved in few days.
After four weeks, neoformed vessels could be clearly seen
by macroscopical examination from the splenic surface to
the subcutaneous veins; angiography by direct splenic
puncture showed the spleen drainage through the splenic
vein and neoformed collaterals to the superior vena cava
by thoraco-epigastric vein and to the inferior vena cava by
superficial epigastric vein (Figure 1).
Cavo-portal transposition
The surgical procedure required a median of 50–60 min-
utes, with 10–15 min for cavo-portal anastomosis. Dis-
crepancy of caliber between veins was overcome by small
longitudinal incisions on the anterior and posterior wall
of the portal vein. The final result is showed in figure 2.Page 2 of 6
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selective mesenteric angiography that showed total
mesenteric blood flow diversion through the spleen to the
superior and inferior vena cava (Figure 3). Macroscopical
examination revealed normal bowel and liver appearance,
absence of intestinal wall edema and no ascites.
Discussion
Diffuse portal thrombosis is no longer a contraindication
for liver transplantation.
Since the report of Tzakis et al. [4], the use of caval blood
as portal inflow as been described as valuable strategy to
Left side: angiography by direct splenic puncture shows the physiological venous drainage through the splenic vein to the portal v in; neo formed capillaries connect the spleen with the su erior vena cava through thoraco-epigastric vein, and the inferior na cava thr ugh the superficial pigastric v inFigure 1
Left side: angiography by direct splenic puncture shows the physiological venous drainage through the splenic vein to the portal 
vein; neo formed capillaries connect the spleen with the superior vena cava through thoraco-epigastric vein, and the inferior 
vena cava through the superficial epigastric vein. Right side: macroscopical examination shows the collaterals connecting the 
transposed spleen with the thoraco-epigastric vein and the superficial epigastric vein. sp = spleen, spv = splenic vein, tev = tho-
raco-epigastric vein, sev = superficial epigastric vein.Page 3 of 6
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splanchnic venous thrombosis [5-8,12,13]. In this setting,
stabilized inframesocolic porto-systemic shunts are essen-
tial to guarantee splanchnic venous drainage in to the sys-
temic circulation and to assure hepatotropic factors to the
liver by systemic blood flow [7].
However, the clinical data available are heterogeneous,
and further experimental studies are necessary to clarify
the role of systemic blood inflow by porto-caval transpo-
sition on liver function [8,14].
In pre-transplant era, Child et al. reported normal liver
function and normal liver regeneration after porto-caval
transposition in dog, showing that physiological splanch-
nic blood flow could be replaced by systemic blood flow
via the portal vein [11]. More recently the influence of sys-
temic circulation on liver function has been investigated
using a rat model of porto-caval transposition [9]. These
studies suggested that the major determinant of the meta-
bolic function of the liver is the amount of portal blood
flow rather than its source.
However, these experimental models are challenging and
they do not reproduce comparable clinical hemodynamic
conditions, since the absence of splanchnic inframeso-
colic collaterals to the systemic circulation.
This new technique of cavoportal transposition, with pre-
viously induced porto-systemic shunts, is simple: it avoids
The liver is reperfused after cavo-portal transpositionFigure 2
The liver is reperfused after cavo-portal transposition. pv = portal vein, cv = vena cava, smv = superior mesenteric vein, pdv = 
pancreatic-duodenal vein, rrv = right renal vein, lrv = left renal vein, cbd = common bile duct, ln = linfonode, rk = right kidney, 
sb = small bowelPage 4 of 6
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Selective mesenteric vein angiography after cavo-portal transposition: splanchnic flow is shunted to the vena cava system through the n o-form d port -caval shuntsFigure 3
Selective mesenteric vein angiography after cavo-portal transposition: splanchnic flow is shunted to the vena cava system 
through the neo-formed porto-caval shunts. smv = superior mesenteric vein, spv = splenic vein, icv = intercostal veins, itv = 
internal thoracic vein, tev = thoraco-epigastric vein, sev = superficial epigastric vein.
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the need of complex microsurgical reconstruction using
vascular grafts from other animal, as previously described
[9], and it leads to a quick and easy performance.
This model simulates the clinical hemodynamic condi-
tion since the porto-systemic shunts induced by subcuta-
neous splenic transposition represent the physiological
collaterals induced by chronic portal thrombosis in man.
It is effective: the induced shunts ensure an adequate
splanchnic venous drainage as showed by angiography,
and confirmed by the normal appearance of bowel and
the absence of any signs of edema or ascites.
In addition, it can be used to study the liver regeneration
and the ischemic precondition during cavo-portal trans-
position, indeed it is also suitable for whole or reduced
liver transplantation with caval inflow.
Conclusion
The technique we describe represents in our opinion the
more realistic model of cavo-portal transposition in small
animal: it is simple and effective, and it could be a valua-
ble tool in studying the metabolic function of the liver
with caval inflow in presence of total splanchnic flow
diversion.
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